SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001615219-23-000030
Filing Date
2023-03-27
Accepted
2023-03-27 08:59:45
Documents
53
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 10-K flks-20221231.htm   iXBRL 10-K 1063141
2 EX-23.1 a2022eyconsent-draft.htm EX-23.1 5935
3 EX-31.1 slrx20221231ex-311.htm EX-31.1 10795
4 EX-31.2 slrx12312022-312expfocerti.htm EX-31.2 10802
5 EX-32.1 slrx12312022-321ex906peoce.htm EX-32.1 5627
6 EX-32.2 slrx12312022-322ex906pfoce.htm EX-32.2 5504
12 flks-20221231_g1.jpg GRAPHIC 484999
  Complete submission text file 0001615219-23-000030.txt   4996472

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT flks-20221231.xsd EX-101.SCH 22296
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT flks-20221231_cal.xml EX-101.CAL 38473
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT flks-20221231_def.xml EX-101.DEF 91044
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT flks-20221231_lab.xml EX-101.LAB 356418
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT flks-20221231_pre.xml EX-101.PRE 228130
47 EXTRACTED XBRL INSTANCE DOCUMENT flks-20221231_htm.xml XML 306549
Mailing Address 2450 HOLCOMBE BLVD SUITE J-608 HOUSTON TX 77021
Business Address 2450 HOLCOMBE BLVD SUITE J-608 HOUSTON TX 77021 346-772-0346
Salarius Pharmaceuticals, Inc. (Filer) CIK: 0001615219 (see all company filings)

IRS No.: 465087339 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36812 | Film No.: 23761576
SIC: 2834 Pharmaceutical Preparations